{"id":"W4296965640","doi":"10.1016/s2152-2650(22)01601-9","title":"MM-188 Depth of Response of Isatuximab plus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: IKEMA Updated Analysis","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Saint John Regional Hospital; Dalhousie University; University of New Brunswick","funders":"","keywords":"Medicine; Internal medicine; Carfilzomib; Clinical endpoint; Multiple myeloma; Dexamethasone; Oncology; Nuclear medicine; Gastroenterology; Surgery; Randomized controlled trial; Lenalidomide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002368333,0.0004402171,0.001816497,0.001301456,0.0001194634,0.001157177,0.0006866113,0.0003872511,0.00235702],"category_scores_gemma":[0.003539949,0.0002387891,0.002010746,0.001560483,0.0001755143,0.0006916384,0.0005099723,0.0009726862,0.0004498471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001067298,"about_ca_system_score_gemma":0.0008480129,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00197374,"about_ca_topic_score_gemma":0.005152537,"domain_scores_codex":[0.9990739,0.0002251761,0.0001748073,0.0001427339,0.0002841981,0.00009917971],"domain_scores_gemma":[0.9974721,0.0009388428,0.0008932429,0.0001469134,0.0004132187,0.000135658],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01823524,0.000376527,0.1479465,0.005792565,0.009236977,0.0002191186,0.0001288672,0.001764018,0.004190631,0.0004193169,0.01670742,0.7949829],"study_design_scores_gemma":[0.003444652,0.005557667,0.8560994,0.001796887,0.0220375,0.001579599,0.0001996014,0.002108785,0.003990879,0.0005756522,0.1025025,0.0001068291],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4552578,0.4943061,0.00270517,0.003668219,0.0008629594,0.0004444948,0.02048362,0.000374304,0.02189736],"genre_scores_gemma":[0.8637376,0.09835494,0.004789439,0.003161345,0.001566774,0.0003453971,0.02360667,0.0001086729,0.004329081],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002368333,"threshold_uncertainty_score":0.01252508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04308698812435666,"score_gpt":0.3477224056793199,"score_spread":0.3046354175549633,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}